Sanofi (SNY) Income from Non-Controlling Interests (2009 - 2026)

Sanofi has disclosed Income from Non-Controlling Interests across 18 years of filings, most recently posting $7.0 million for Q1 2026.

• Income from Non-Controlling Interests for Q1 2026 came in at $7.0 million, down 68.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.8 million (up 3.87% YoY), and the FY2025 annual result was $44.2 million, down 28.63% from the prior year.
• Income from Non-Controlling Interests came in at $7.0 million for Q1 2026 at Sanofi, up from -$21.0 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of $115.3 million in Q4 2022 to a low of -$40.9 million in Q2 2024.
• The 5-year median for Income from Non-Controlling Interests is $13.1 million (2023), against an average of $16.5 million.
• Across the five-year window, Income from Non-Controlling Interests soared 907.79% in 2022 and tumbled 413.17% in 2024, its largest moves.
• Sanofi's Income from Non-Controlling Interests stood at $115.3 million in 2022, then slumped by 102.8% to -$3.2 million in 2023, then jumped by 497.27% to $12.8 million in 2024, then tumbled by 263.4% to -$21.0 million in 2025, then soared by 133.53% to $7.0 million in 2026.
• The last three Income from Non-Controlling Interests figures came in at $7.0 million (Q1 2026), -$21.0 million (Q4 2025), and $36.2 million (Q3 2025), per Business Quant data.